Senate Bill S8187

2021-2022 Legislative Session

Requires insurance coverage for home test kits for sexually transmitted diseases

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Insurance Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2021-S8187 (ACTIVE) - Details

Current Committee:
Senate Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2023-2024 Legislative Session:
S1002

2021-S8187 (ACTIVE) - Summary

Requires health insurance coverage for home test kits for sexually transmitted diseases.

2021-S8187 (ACTIVE) - Sponsor Memo

2021-S8187 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8187
 
                             I N  S E N A T E
 
                             February 1, 2022
                                ___________
 
 Introduced  by  Sen. HOYLMAN -- read twice and ordered printed, and when
   printed to be committed to the Committee on Insurance
 
 AN ACT to amend the insurance  law,  in  relation  to  requiring  health
   insurance  coverage  for  home  test  kits  for  sexually  transmitted
   diseases
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.    Subsection  (i) of section 3216 of the insurance law is
 amended by adding a new paragraph 36 to read as follows:
   (36) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL OR MEDICAL  COVER-
 AGE  OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR
 DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR HOME TEST KITS  FOR
 SEXUALLY  TRANSMITTED  DISEASES.   FOR PURPOSES OF THIS PARAGRAPH, "HOME
 TEST KIT"  MEANS A PRODUCT USED FOR A TEST RECOMMENDED  BY  THE  FEDERAL
 CENTERS  FOR  DISEASE  CONTROL  AND  PREVENTION GUIDELINES OR THE UNITED
 STATES PREVENTIVE SERVICES TASK FORCE, THAT HAS BEEN CLINICAL LABORATORY
 IMPROVEMENT AMENDMENTS OF 1988-WAIVED, CLEARED OR APPROVED BY THE UNITED
 STATES FOOD AND DRUG ADMINISTRATION, OR DEVELOPED  BY  A  LABORATORY  IN
 ACCORDANCE  WITH ESTABLISHED REGULATIONS AND QUALITY STANDARDS, TO ALLOW
 INDIVIDUALS TO SELF-COLLECT SPECIMENS FOR SEXUALLY TRANSMITTED DISEASES,
 INCLUDING HIV, REMOTELY AT A LOCATION OUTSIDE OF A CLINICAL SETTING.
   § 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 22 to read as follows:
   (22) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL OR MEDICAL  COVER-
 AGE  OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT FOR
 DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR HOME TEST KITS  FOR
 SEXUALLY  TRANSMITTED  DISEASES.   FOR PURPOSES OF THIS PARAGRAPH, "HOME
 TEST KIT"  MEANS A PRODUCT USED FOR A TEST RECOMMENDED  BY  THE  FEDERAL
 CENTERS  FOR  DISEASE  CONTROL  AND  PREVENTION GUIDELINES OR THE UNITED
 STATES PREVENTIVE SERVICES TASK FORCE, THAT HAS BEEN CLINICAL LABORATORY
 IMPROVEMENT AMENDMENTS OF 1988-WAIVED, CLEARED OR APPROVED BY THE UNITED
 STATES FOOD AND DRUG ADMINISTRATION, OR DEVELOPED  BY  A  LABORATORY  IN
 ACCORDANCE  WITH ESTABLISHED REGULATIONS AND QUALITY STANDARDS, TO ALLOW
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD14420-02-2
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.